Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Higaki

Showing results (21-30 of 262) with videos related to

Pageof 27
Sort By:
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|April 1, 1989
Measurements of enzyme activity and immunoreactivity of plasma renin. Limitations of the conventional method for assay of plasma renin catalytic activityJ Higaki, R Morishita, T Ogihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1996
[Bartter syndrome]T Katsuya, J Higaki, T Ogihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 12, 2000
[Genetics of essential hypertension]T Katsuya, J Higaki, T Ogihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 12, 2000
[Angiotensin II type 1 receptor gene]T Katsuya, J Higaki, T Ogihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 11, 1999
[Gene loci and polymorphisms of angiotensin II receptor]T Katsuya, J Higaki, T Ogihara
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|April 18, 2001
[Gene and elderly hypertension]J Higaki, T Katsuya, T Ogihara
Journal of Neurochemistry|January 1, 1997
Inhibition of beta-amyloid formation by haloperidol: a possible mechanism for reduced frequency of Alzheimer's disease pathology in schizophreniaJ Higaki, G M Murphy, B Cordell
Experimental Nephrology|December 5, 1997
A novel strategy for gene therapy and gene regulation analysis using transcription factor decoy oligonucleotidesN Tomita, R Morishita, J Higaki, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 29, 2000
[Genes and hypertension]J Higaki, T Katsuya, R Morishita, et al.
Journal of Atherosclerosis and Thrombosis|June 27, 2001
Novel molecular therapeutic approach to cardiovascular disease based on hepatocyte growth factorN Tomita, R Morishita, J Higaki, et al.
Pageof 27

Showing results (21-30 of 262) with videos related to

Sort By:
Pageof 27
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|April 1, 1989
Measurements of enzyme activity and immunoreactivity of plasma renin. Limitations of the conventional method for assay of plasma renin catalytic activityJ Higaki, R Morishita, T Ogihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1996
[Bartter syndrome]T Katsuya, J Higaki, T Ogihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 12, 2000
[Genetics of essential hypertension]T Katsuya, J Higaki, T Ogihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 12, 2000
[Angiotensin II type 1 receptor gene]T Katsuya, J Higaki, T Ogihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 11, 1999
[Gene loci and polymorphisms of angiotensin II receptor]T Katsuya, J Higaki, T Ogihara
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|April 18, 2001
[Gene and elderly hypertension]J Higaki, T Katsuya, T Ogihara
Journal of Neurochemistry|January 1, 1997
Inhibition of beta-amyloid formation by haloperidol: a possible mechanism for reduced frequency of Alzheimer's disease pathology in schizophreniaJ Higaki, G M Murphy, B Cordell
Experimental Nephrology|December 5, 1997
A novel strategy for gene therapy and gene regulation analysis using transcription factor decoy oligonucleotidesN Tomita, R Morishita, J Higaki, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 29, 2000
[Genes and hypertension]J Higaki, T Katsuya, R Morishita, et al.
Journal of Atherosclerosis and Thrombosis|June 27, 2001
Novel molecular therapeutic approach to cardiovascular disease based on hepatocyte growth factorN Tomita, R Morishita, J Higaki, et al.
Pageof 27